PCRX dividend yield: 4.00%. ARCC dividend yield: 9.06%. PCRX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in PCRX shares. Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
PCRX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in PCRX shares.
Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Is PCRX or ARCC better for dividend income in 2026?
PCRX currently offers a 4.00% yield (2.00/share/year) while ARCC offers 9.06% (1.92/share/year). ARCC provides higher current income. However, PCRX has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in PCRX vs ARCC earn per year?
With $10,000 invested today: PCRX pays approximately $400/year. ARCC pays approximately $906/year. With DRIP reinvestment over 10 years, these grow to $899/year (PCRX) and $2,279/year (ARCC).
Does PCRX or ARCC pay monthly dividends?
PCRX pays quarterly dividends. ARCC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this PCRX vs ARCC comparison by email
Save your analysis + get weekly dividend insights. Free forever.